Reduction in IL‐1β, IL‐6, TNF‐α, PGE2, and MIP‐1‐α in microglia (1, 10, and 25 μM) VCE‐003 ameliorated MS symptoms induced by TMEV. This evidence concerns the gene IL1B and myeloid sarcoma.